Flip 2 coins. This attack does 10 damage times the number of heads.
Flip a coin. If heads, during your opponent's next turn, prevent all effects of attacks, including damage, done to Skarmory.
Neo Revelation was released in 2001. It belongs to the Neo series.
Set size is 66 cards, which categorizes Neo Revelation as compact. As of 2026, the set is 25 years old and fits a legacy-era profile.
Within this set, Skarmory is card number 23 with a Rare designation.
Skarmory appears in Neo Revelation, released in 2001. Card flavor text reads: "After nesting in bramble bushes, the wings of its chicks grow hard from scratches by thorns." Core profile: Its card type is Pokémon.
The rarity label is Rare. Printed HP is 60.
Energy typing is Metal. Card subtype classification is Basic.
Notable move text references "Fury Attack" and "Agility". This card is weak to Fire energy and resists Grass.
Current market pricing for Skarmory (Neo Revelation) sits near $21.87. Week-over-week change is limited (0.0%), indicating short-term stability.
Current pricing is broadly aligned with its 30-day average ($21.60). The 90-day window shows a floor near $12.65 and a peak around $21.87 (42% total spread), which maps to moderate-volatility movement.
This version is categorized as Rare.
Skarmory sits within a broader pool of Skarmory variants that can be compared by set, rarity, and price. Comparable entries in this snapshot: 6 cards, 5 distinct sets.
In this sample, pricing ranges between $0.06 and $7.44 (12300% total span). Relative to the alternative average ($1.37), this card is +1500%.
Notable alternatives include Skarmory #69 (Roaring Skies) at $0.27, Skarmory #59 (Phantom Forces) at $0.21, Skarmory #182 (Fusion Strike) at $0.06, and Skarmory #120 (Darkness Ablaze) at $0.14.
Current valuation lens: The latest week is near flat (0.0%), suggesting consolidation rather than breakout behavior. Observed 90-day bounds of $12.65 and $21.87 create a 42% band, matching a moderate-volatility profile.
Current value remains close to its 30-day mean ($21.60). Condition sensitivity is substantial: PSA 10 carries a +771% premium over raw value.
PSA 9 is currently around $19.05, while PSA 10 is $190.54.
